Member-only story
America Is Having a Plastic Surgery and Botox Bonanza
The vaccines are coming — and everyone’s rushing to get lip injections
In June, Susie Sessoms got her first lip filler. In November, she tried Kybella, the “fat dissolving” double chin injectable. “I swelled up like a bullfrog,” she says. “It’s a good thing I didn’t have to go to work!” Like many office workers, Sessoms, a mortgage executive in the Twin Cities, has worked from home from March of last year. Her company doesn’t do Zoom, which made it even easier to get treatments discreetly. “I wasn’t concerned about catching Covid,” she says. Her medspa’s sanitization protocols make her feel safer than at the grocery store.
Like so many businesses in the pandemic, cosmetic surgeons took a big hit last March; there was less interest in beautification and more focus on shelter in place and toilet paper supplies. Across America, shutdowns for elective cosmetic work varied wildly; New York closed for three months, Minnesota for seven weeks, and so on. Some places never reopened. In July 2020, AbbVie, the pharmaceutical firm that owns Botox, reported a huge dip in global net revenues from sales of cosmetic Botox — down to $226 million, a 43.1% decrease from 2019.
Then, a shift. Practices reopened. Phones rang. Appointment after appointment was booked. AbbVie’s…
